Pneumeric, Inc. Partners with JP Pharma for Capnospot® Distribution in Brazil
Pneumeric, Inc. has signed a distribution agreement with JP Pharma to make the Capnospot® Tension Pneumothorax Decompression Indicator available in Brazil. This device informs emergency responders about successful decompression, enhancing patient safety. Key figures from both companies have expressed optimism about the partnership’s impact on healthcare practices in Brazil.
Pneumeric, Inc. has finalized a distribution agreement with JP Pharma, one of the largest tactical medical suppliers in Latin America, to distribute the Capnospot® Tension Pneumothorax Decompression Indicator across Brazil. This life-saving device simplifies tension pneumothorax procedures by providing visual confirmation through a color change, which expedites treatment for medical responders.
JP Pharma is known for its collaboration with global medical device manufacturers, thereby enhancing competition in Brazil’s medical marketplace. The inclusion of the Capnospot® device aligns well with both companies’ goals and operational strategies.
Bruno Tavora, the Chief Operating Officer of JP Pharma, expressed enthusiasm for the partnership, emphasizing a shared commitment to pre-hospital care innovation. He stated, “I am thrilled about JP Pharma’s new partnership with Pneumeric, a company that shares our passion for innovation in pre-hospital care.”
Deon Miller, Chief Commercial Officer of Pneumeric, Inc., also highlighted the promising nature of the agreement, stating, “We believe this partnership will be mutually beneficial for both companies and look forward to working with JP Pharma to launch the technologically advanced Capnospot into the Brazilian market.”
Capnospot® enhances the efficacy of tension pneumothorax decompression procedures by offering real-time confirmation of decompression success, thereby improving patient outcomes. Pneumeric, established in 2021, holds two patents for Capnospot® and received FDA clearance in 2023. For more details on Capnospot® and Pneumeric, visit www.pneumeric-medical.com.
Founded in 2008, JP Pharma focuses on empowering Brazilian healthcare through strategic partnerships and innovative medical products. More information is available at www.jppharma.com.br.
The partnership between Pneumeric, Inc. and JP Pharma signifies a substantial advancement in emergency medical response capabilities in Brazil. The Capnospot® Tension Pneumothorax Decompression Indicator stands to enhance patient care and improve outcomes in critical conditions. This collaboration highlights the ongoing commitment to integrating innovative medical technologies in pre-hospital settings.
Original Source: www.prweb.com
